morphiceptin has been researched along with norbinaltorphimine in 1 studies
Studies (morphiceptin) | Trials (morphiceptin) | Recent Studies (post-2010) (morphiceptin) | Studies (norbinaltorphimine) | Trials (norbinaltorphimine) | Recent Studies (post-2010) (norbinaltorphimine) |
---|---|---|---|---|---|
139 | 0 | 12 | 918 | 0 | 205 |
Protein | Taxonomy | morphiceptin (IC50) | norbinaltorphimine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0104 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0029 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.212 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.024 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0036 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, S; Li, M; Ma, G; Zhou, L | 1 |
1 other study(ies) available for morphiceptin and norbinaltorphimine
Article | Year |
---|---|
Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide.
Topics: Analgesia; Analgesics, Opioid; Animals; Arginine; Dose-Response Relationship, Drug; Endorphins; Guinea Pigs; Male; Mice; Morphinans; Naloxone; Naltrexone; Neuropeptides; Opioid Peptides; Proline; Receptors, Neuropeptide; Tetrahydroisoquinolines; Time Factors | 2012 |